{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:28:44Z","timestamp":1789669724339,"version":"4.0.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.atherosclerosis.2024.119066","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:34:21Z","timestamp":1732606461000},"page":"119066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["De novo lipid synthesis in cardiovascular tissue and disease"],"prefix":"10.1016","volume":"400","author":[{"given":"Tariq J.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay F.","family":"Semenkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl 2","key":"10.1016\/j.atherosclerosis.2024.119066_bib1","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0026-0495(78)80004-3","article-title":"Carbohydrate storage in man: speculations and some quantitative considerations","volume":"27","author":"Bj\u00f6rntorp","year":"1978","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib2","doi-asserted-by":"crossref","first-page":"e014119","DOI":"10.1161\/JAHA.119.014119","article-title":"Serial biomarkers of de novo lipogenesis fatty acids and incident heart failure in older adults: the cardiovascular health study","volume":"9","author":"Lee","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12964-021-00767-2","article-title":"Ceramide from sphingomyelin hydrolysis induces neuronal differentiation, whereas de novo ceramide synthesis and sphingomyelin hydrolysis initiate apoptosis after NGF withdrawal in PC12 Cells","volume":"20","author":"Kagan","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"12, Supplement 2","key":"10.1016\/j.atherosclerosis.2024.119066_bib4","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0026-0495(78)80004-3","article-title":"Carbohydrate storage in man: speculations and some quantitative considerations","volume":"27","author":"Bj\u00f6rntorp","year":"1978","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","article-title":"Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets1,2,3","volume":"77","author":"Schwarz","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119066_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.82922","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","article-title":"Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets","volume":"77","author":"Schwarz","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10409231003667500","article-title":"Genetic control of de novo lipogenesis: role in diet-induced obesity","volume":"45","author":"Strable","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib9","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.2014-3678","article-title":"Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat","volume":"100","author":"Schwarz","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib10","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0270","article-title":"Fructose drives de novo lipogenesis affecting metabolic health","volume":"257","author":"Geidl-Flueck","year":"2023","journal-title":"J. Endocrinol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","article-title":"Fructose stimulated de novo lipogenesis is promoted by inflammation","volume":"2","author":"Todoric","year":"2020","journal-title":"Nat. Metab."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119066_bib12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1535-7163.MCT-12-0095","article-title":"ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms","volume":"11","author":"Zaidi","year":"2012","journal-title":"Mol. Cancer. Ther"},{"issue":"35","key":"10.1016\/j.atherosclerosis.2024.119066_bib13","doi-asserted-by":"crossref","first-page":"30949","DOI":"10.1074\/jbc.M111.230508","article-title":"Fatty acid synthase modulates homeostatic responses to myocardial stress","volume":"286","author":"Razani","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.atherosclerosis.2024.119066_bib14","doi-asserted-by":"crossref","first-page":"27014","DOI":"10.1074\/jbc.M203458200","article-title":"Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice","volume":"277","author":"Nielsen","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib15","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1074\/jbc.M110.193037","article-title":"De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cmet.2018.07.019","article-title":"Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR Malonylation","volume":"28","author":"Bruning","year":"2018","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI96702","article-title":"Fructose metabolism and metabolic disease","volume":"128","author":"Hannou","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"issue":"51","key":"10.1016\/j.atherosclerosis.2024.119066_bib20","doi-asserted-by":"crossref","first-page":"17877","DOI":"10.1074\/jbc.REV120.013529","article-title":"Genetic diseases of the Kennedy pathways for membrane synthesis","volume":"295","author":"Tavasoli","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib22","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1080\/10408398.2015.1018045","article-title":"Palmitic acid in early human development","volume":"56","author":"Innis","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1471-4159.1998.70031227.x","article-title":"Fatty acid transport and utilization for the developing brain","volume":"70","author":"Edmond","year":"1998","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.numecd.2010.03.001","article-title":"The third Italian national food consumption survey, INRAN-SCAI 2005-06--part 1: nutrient intakes in Italy","volume":"21","author":"Sette","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101383","article-title":"Regulation and metabolic significance of de novo lipogenesis in adipose tissues","volume":"10","author":"Song","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","article-title":"Phospholipid remodeling in physiology and disease","volume":"81","author":"Wang","year":"2019","journal-title":"Annu. Rev. Physiol."},{"issue":"42","key":"10.1016\/j.atherosclerosis.2024.119066_bib27","doi-asserted-by":"crossref","first-page":"29683","DOI":"10.1074\/jbc.274.42.29683","article-title":"Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine Methylation pathway","volume":"274","author":"DeLong","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1194\/jlr.R700019-JLR200","article-title":"Thematic review series: Glycerolipids. Phosphatidylcholine and choline homeostasis","volume":"49","author":"Li","year":"2008","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib29","series-title":"Sphingolipid Metabolism and Metabolic Disease","first-page":"31","article-title":"De novo sphingolipid biosynthesis in atherosclerosis","author":"Park","year":"2022"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.plipres.2013.05.001","article-title":"Biological functions of sphingomyelins","volume":"52","author":"Slotte","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3945\/ajcn.111.012054","article-title":"Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study","volume":"94","author":"Wu","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ajcn\/88.1.203","article-title":"Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study","volume":"88","author":"Warensj\u00f6","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"38","key":"10.1016\/j.atherosclerosis.2024.119066_bib34","doi-asserted-by":"crossref","first-page":"eadf9037","DOI":"10.1126\/sciadv.adf9037","article-title":"Circulating fatty acids, genetic risk, and incident coronary artery disease: a prospective, longitudinal cohort study","volume":"9","author":"Zhuang","year":"2023","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcn\/87.4.817","article-title":"Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding","volume":"87","author":"Chong","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cen.14459","article-title":"Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans","volume":"95","author":"Simons","year":"2021","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119066_bib37","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cen.14459","article-title":"Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans","volume":"95","author":"Simons","year":"2021","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib40","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1016\/j.numecd.2022.09.003","article-title":"Association between de novo lipogenesis susceptibility genes and coronary artery disease","volume":"32","author":"Simons","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib41","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/diabetes.48.10.2022","article-title":"Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia","volume":"48","author":"O'Doherty","year":"1999","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.119066_bib42","doi-asserted-by":"crossref","first-page":"E1125","DOI":"10.1210\/jc.2015-1587","article-title":"Hepatic de novo lipogenesis in obese youth is modulated by a common variant in the GCKR gene","volume":"100","author":"Santoro","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00125-023-05878-8","article-title":"Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice","volume":"66","author":"Lee","year":"2023","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2014.09.012","article-title":"Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice","volume":"62","author":"Peyrou","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib45","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s42255-023-00896-7","article-title":"Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice","volume":"5","author":"Yao","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2019.05.016","article-title":"Circulating serum fatty acid synthase is elevated in patients with diabetes and carotid artery stenosis and is LDL-associated","volume":"287","author":"De Silva","year":"2019","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","article-title":"Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy","volume":"111","author":"Kolwicz","year":"2012","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.119.043319","article-title":"Increasing fatty acid oxidation prevents high-fat diet-induced Cardiomyopathy through regulating Parkin-mediated mitophagy","volume":"142","author":"Shao","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140785","article-title":"Neonatal hyperoxia inhibits proliferation and survival of atrial cardiomyocytes by suppressing fatty acid synthesis","volume":"6","author":"Cohen","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/205648","article-title":"Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain Fatty Acid uptake and de novo Fatty Acid synthesis","volume":"2012","author":"Ge","year":"2012","journal-title":"J Obes"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2024.119066_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189883","article-title":"Stearoyl-CoA desaturase (SCD) induces cardiac dysfunction with cardiac lipid overload and angiotensin II AT1 receptor protein Up-regulation","volume":"22","author":"Abd Alla","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2023.03.003","article-title":"STAT3 signaling promotes cardiac injury by upregulating NCOA4-mediated ferritinophagy and ferroptosis in high-fat-diet fed mice","volume":"201","author":"Zhu","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2015.05.042","article-title":"Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK","volume":"463","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7628","key":"10.1016\/j.atherosclerosis.2024.119066_bib54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature20117","article-title":"Fatty acid synthesis configures the plasma membrane for inflammation in diabetes","volume":"539","author":"Wei","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111569","article-title":"Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension","volume":"383","author":"Singh","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejphar.2017.09.042","article-title":"Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells","volume":"815","author":"Singh","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"30","key":"10.1016\/j.atherosclerosis.2024.119066_bib57","doi-asserted-by":"crossref","first-page":"23398","DOI":"10.1074\/jbc.M110.100321","article-title":"Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis","volume":"285","author":"Schneider","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib58","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphys.2017.00902","article-title":"Palmitic acid: physiological role, metabolism and Nutritional implications","volume":"8","author":"Carta","year":"2017","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119066_bib59","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1161\/ATVBAHA.113.302099","article-title":"Saturated fatty acid palmitate aggravates neointima formation by promoting smooth muscle phenotypic modulation","volume":"33","author":"Shen","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib60","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10495-016-1231-8","article-title":"Sodium orthovanadate suppresses palmitate-induced cardiomyocyte apoptosis by regulation of the JAK2\/STAT3 signaling pathway","volume":"21","author":"Liu","year":"2016","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2020.03.027","article-title":"Palmitate induces cardiomyocyte death via inositol requiring enzyme-1 (IRE1)-mediated signaling independent of X-box binding protein 1 (XBP1)","volume":"526","author":"Yamamoto","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib62","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.3892\/mmr.2017.7404","article-title":"Palmitate induces myocardial lipotoxic injury via the endoplasmic reticulum stress-mediated apoptosis pathway","volume":"16","author":"Zou","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib63","doi-asserted-by":"crossref","first-page":"C888","DOI":"10.1152\/ajpcell.00293.2018","article-title":"Palmitate decreases migration and proliferation and increases oxidative stress and inflammation in smooth muscle cells: role of the Nrf2 signaling pathway","volume":"316","author":"Girona","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib64","doi-asserted-by":"crossref","first-page":"H717","DOI":"10.1152\/ajpheart.00257.2001","article-title":"Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin","volume":"282","author":"Kong","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib65","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/jcb.26501","article-title":"Acute hypoxic preconditioning prevents palmitic acid-induced cardiomyocyte apoptosis via switching metabolic GLUT4-glucose pathway back to CD36-fatty acid dependent","volume":"119","author":"Chen","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1753-0407.12073","article-title":"Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4\/nuclear factor-\u03baB pathway (TLR4\/NF-\u03baB-8)","volume":"6","author":"Quan","year":"2014","journal-title":"J. Diabetes"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib67","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2337\/diabetes.53.12.3209","article-title":"Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells","volume":"53","author":"Staiger","year":"2004","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib68","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2004-1560","article-title":"Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells","volume":"146","author":"Jov\u00e9","year":"2005","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119066_bib69","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/ATVBAHA.109.188813","article-title":"Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation","volume":"29","author":"Maloney","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"24\u201326","key":"10.1016\/j.atherosclerosis.2024.119066_bib70","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.lfs.2013.05.002","article-title":"Palmitate induces apoptosis in mouse aortic endothelial cells and endothelial dysfunction in mice fed high-calorie and high-cholesterol diets","volume":"92","author":"Lu","year":"2013","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.119066_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114516","article-title":"Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation","volume":"43","author":"Leishman","year":"2024","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib72","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tins.2022.03.002","article-title":"Oxidized phospholipids as novel mediators of neurodegeneration","volume":"45","author":"Dong","year":"2022","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.numecd.2017.07.011","article-title":"Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis","volume":"28","author":"Paapstel","year":"2018","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108617","article-title":"Dietary phosphatidylcholine supplementation reduces atherosclerosis in Ldlr(-\/-) male mice(2)","volume":"92","author":"Aldana-Hern\u00e1ndez","year":"2021","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib76","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib77","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1002\/jcp.29518","article-title":"Trimethylamine N-oxide promotes apoE(-\/-) mice atherosclerosis by inducing vascular endothelial cell pyroptosis via the SDHB\/ROS pathway","volume":"235","author":"Wu","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib78","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib79","article-title":"Choline consumption reduces CVD risk via body composition modification","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2016.01.003","article-title":"Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction","volume":"246","author":"Sutter","year":"2016","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1194\/jlr.M081026","article-title":"Diabetes adversely affects phospholipid profiles in human carotid artery endarterectomy plaques","volume":"59","author":"Zayed","year":"2018","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30695-0","article-title":"Phospholipidome of endothelial cells shows a different adaptation response upon oxidative, glycative and lipoxidative stress","volume":"8","author":"Colombo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2017.05.010","article-title":"Atherosclerotic dyslipidemia revealed by plasma lipidomics on ApoE\u2212\/\u2212 mice fed a high-fat diet","volume":"262","author":"Chen","year":"2017","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib84","doi-asserted-by":"crossref","first-page":"23283","DOI":"10.3390\/ijms151223283","article-title":"Lipidome of atherosclerotic plaques from hypercholesterolemic rabbits","volume":"15","author":"Bojic","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib85","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.redox.2017.10.020","article-title":"Lipidomics reveals accumulation of the oxidized cholesterol in erythrocytes of heart failure patients","volume":"14","author":"Tang","year":"2018","journal-title":"Redox Biol."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2024.119066_bib86","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","article-title":"Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide","volume":"35","author":"Wang","year":"2014","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jacl.2022.02.001","article-title":"CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: a systematic review and meta-analysis","volume":"16","author":"Papazoglou","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib88","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41598-022-09225-6","article-title":"Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy","volume":"12","author":"Timmerman","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/VHRM.S202344","article-title":"Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease","volume":"15","author":"Djekic","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2024.119066_bib90","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study","volume":"129","author":"Stegemann","year":"2014","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2024.119066_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163403","article-title":"Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD","volume":"8","author":"Fan","year":"2023","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib92","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/db20-0635","article-title":"CEPT1-Mediated phospholipogenesis regulates endothelial cell function and ischemia-induced angiogenesis through PPAR\u03b1","volume":"70","author":"Zayed","year":"2021","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.119066_bib93","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.122.318048","article-title":"Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential","volume":"42","author":"Zietzer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119066_bib94","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tem.2016.07.005","article-title":"Sphingolipid de novo biosynthesis: a Rheostat of cardiovascular homeostasis","volume":"27","author":"Sasset","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119066_bib95","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.numecd.2017.08.007","article-title":"Western diet increases cardiac ceramide content in healthy and hypertrophied hearts","volume":"27","author":"Butler","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2018.06.054","article-title":"Sphingomyelin phosphodiesterase 1 (SMPD1) mediates the attenuation of myocardial infarction-induced cardiac fibrosis by astaxanthin","volume":"503","author":"Shi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib97","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","article-title":"Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice","volume":"58","author":"Park","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbalip.2009.01.010","article-title":"Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol","volume":"1791","author":"Li","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib99","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","article-title":"Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119066_bib100","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/ATVBAHA.110.213363","article-title":"Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis","volume":"30","author":"Fan","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib101","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1194\/jlr.M600040-JLR200","article-title":"Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice","volume":"47","author":"Dong","year":"2006","journal-title":"JLR (J. Lipid Res.)"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-10-7","article-title":"Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice","volume":"10","author":"Wang","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12933-022-01596-4","article-title":"Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study","volume":"21","author":"Jensen","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"4A","key":"10.1016\/j.atherosclerosis.2024.119066_bib104","doi-asserted-by":"crossref","first-page":"13B","DOI":"10.1016\/S0002-9149(98)00032-0","article-title":"Atherogenicity of triglyceride-rich lipoproteins","volume":"81","author":"Krauss","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9149(90)90017-U","article-title":"Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease","volume":"65","author":"Miller","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119066_bib106","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/gerona\/glaa072","article-title":"Ceramide biomarkers predictive of cardiovascular disease risk increase in healthy Older adults after bed rest","volume":"75","author":"Petrocelli","year":"2020","journal-title":"J. Gerontol.: Series A"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12933-022-01596-4","article-title":"Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study","volume":"21","author":"Jensen","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib108","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI97949","article-title":"Role of sphingolipids in senescence: implication in aging and age-related diseases","volume":"128","author":"Trayssac","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2020.09.004","article-title":"Associations between plasma ceramides and mortality in patients with coronary artery disease","volume":"314","author":"Li","year":"2020","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119066_bib110","doi-asserted-by":"crossref","first-page":"e005708","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708","article-title":"Plasma ceramides and sphingomyelins in relation to heart failure risk","volume":"12","author":"Lemaitre","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010135","article-title":"Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure","volume":"10","author":"P\u00e9rez-Carrillo","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib112","doi-asserted-by":"crossref","first-page":"H599","DOI":"10.1152\/ajpheart.00314.2021","article-title":"Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts","volume":"321","author":"S","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib113","doi-asserted-by":"crossref","first-page":"e012853","DOI":"10.1161\/JAHA.119.012853","article-title":"Plasma ceramides and sphingomyelins in relation to atrial fibrillation risk: the cardiovascular health study","volume":"9","author":"Jensen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib114","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/ATVBAHA.109.199281","article-title":"Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: multi-Ethnic Study of Atherosclerosis","volume":"30","author":"Yeboah","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.119066_bib115","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma ceramides","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib116","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119066_bib117","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/db07-0123","article-title":"Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms","volume":"56","author":"Zhang","year":"2007","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.119066_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012057","article-title":"Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice","volume":"5","author":"Noguchi","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib119","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1152\/ajpendo.00014.2009","article-title":"Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways","volume":"297","author":"Uebanso","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib120","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101196","article-title":"Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction","volume":"48","author":"Gutierrez","year":"2021","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib122","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1039\/C1FO10111K","article-title":"Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat","volume":"3","author":"Janevski","year":"2012","journal-title":"Food Funct."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2024.119066_bib123","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib124","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124819","article-title":"A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans","volume":"4","author":"Charidemou","year":"2019","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.119066_bib125","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than Unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2024.119066_bib126","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150996","article-title":"Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease","volume":"131","author":"Cohen","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhep.2021.02.027","article-title":"Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial","volume":"75","author":"Geidl-Flueck","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib134","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000871","article-title":"Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism","volume":"8","author":"Green","year":"2020","journal-title":"BMJ. Open. Diabetes. Res. Care."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.31000","article-title":"Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities","volume":"72","author":"Syed-Abdul","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.plefa.2018.03.009","article-title":"Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and \u03946- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial","volume":"132","author":"Pranger","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119066_bib131","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hep.29246","article-title":"Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study","volume":"66","author":"Stiede","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119066_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100474","article-title":"Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: a phase 1b study","volume":"2","author":"Fouqueray","year":"2021","journal-title":"Cell Reports Medicine"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119066_bib135","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00003246-199805000-00018","article-title":"Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients","volume":"26","author":"Tappy","year":"1998","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119066_bib136","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2010-2007","article-title":"A dual sugar challenge test for lipogenic sensitivity to dietary fructose","volume":"96","author":"Hudgins","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119066_bib137","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/ajcn.112.038695","article-title":"Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans","volume":"96","author":"Sevastianova","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2024.119066_bib128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2017.02.021","article-title":"Fatty acid synthase \u2013 modern tumor cell biology insights into a classical oncology target","volume":"177","author":"Buckley","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119066_bib132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep4.1799","article-title":"Direct AMPK activation corrects NASH in rodents through metabolic effects and direct action on inflammation and fibrogenesis","volume":"6","author":"Gluais-Dagorn","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T17:19:03Z","timestamp":1733764743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024012383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":137,"alternative-id":["S0021915024012383"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119066","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De novo lipid synthesis in cardiovascular tissue and disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119066"}}